Residual Schizophrenia

Residual Schizophrenia is a form of mental illness which is characterized by persisting symptoms that were once part of another mental disorder. This can include affective flattening (minimized emotional expressions), alogia (reduced speech), avolition (an inability to initiate or persist in goal-directed activities), and anhedonia (difficulty in feeling pleasure). Residual Schizophrenia is a chronic, long-term condition that can be challenging to treat and often requires lifelong management. Treatments include antipsychotic medications, psychotherapy, cognitive-behavioral therapy, and support groups. Prognosis can vary greatly, depending on the individual and the course of their illness. Early detection and treatment can help improve outcomes for those with residual Schizophrenia.

← Journal of Schizophrenia Disorders And Therapy

Related Articles

6 article(s) found
Waste Clay for Biodiesel Through Base Catalyzed Transesterification of Residual Cotton Seed Oil.
Full-text HTML Download PDF Download XML
Obesity in Schizophrenia
Full-text HTML Download PDF Download XML
Addressing the gastrointestinal health associated with schizophrenia: The argument for a new nutrition-based intervention
Full-text HTML Download PDF Download XML
Perioperative Period is a Critical Gap for Minimal Residual Cancer Cells Progression and Therapy: Biological and Molecular Based Evidences
Full-text HTML Download PDF Download XML
Retinal and Cortical Contributions to Excessive V1 Neuron Firing Rate Variability in Schizophrenia: A Computational Modeling Analysis
Full-text HTML Download PDF Download XML
Prevalence and Determinants of Metabolic Syndrome in Schizophrenia Patients Treated with Antipsychotics Medications
Full-text HTML Download PDF Download XML